| Identification | Back Directory | [Name]
3-[(3-Chloro-2-methoxyphenyl)amino]-2-[3-[(2S)-1,4-dioxan-2-ylmethoxy]-4-pyridinyl]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one | [CAS]
2521285-05-0 | [Synonyms]
3-(3-chloro-2-methoxy-anilino)-2-[3-[[(2S)-1,4-dioxan-2-yl]methoxy]-4-pyridyl]-1,5,6,7-tetrahydropyrrolo[3,2-c]pyridin-4-one
3-[(3-Chloro-2-methoxyphenyl)amino]-2-[3-[(2S)-1,4-dioxan-2-ylmethoxy]-4-pyridinyl]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one | [Molecular Formula]
C24H25ClN4O5 | [MOL File]
2521285-05-0.mol | [Molecular Weight]
484.93 |
| Chemical Properties | Back Directory | [Boiling point ]
730.8±60.0 °C(Predicted) | [density ]
1.361±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted) | [pka]
13.38±0.20(Predicted) | [InChIKey]
VYQVHWNNPKOJEA-AWEZNQCLSA-N | [SMILES]
C1(=O)NCCC2NC(C3C=CN=CC=3OC[C@@H]3COCCO3)=C(NC3=CC=CC(Cl)=C3OC)C1=2 |
| Hazard Information | Back Directory | [Uses]
Sevabertinib is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor with antitumor activity[1]. | [References]
[1] International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 38, No. 2, 2024. |
|
|